Brii Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	133	92	213	687	3,039	-
Market Cap Growth	24.83%	-56.66%	-69.03%	-77.38%	-	-
Enterprise Value	-164	-242	-171	199	3,764	-
Last Close Price	0.19	0.13	0.23	0.95	-	-
PS Ratio	33.09	13.49	27.01	38.77	208.62	-
PB Ratio	0.39	0.26	0.49	1.50	5.83	-
P/TBV Ratio	0.44	0.27	0.53	1.56	5.79	-
EV/Sales Ratio	-	-	-	11.22	258.41	-
Debt / Equity Ratio	0.00	0.01	0.00	0.00	0.01	-1.39
Asset Turnover	0.01	0.02	0.02	0.04	0.04	0.07
Quick Ratio	42.68	29.97	21.70	13.33	12.13	1.88
Current Ratio	42.98	31.18	22.11	13.43	12.16	1.90
Return on Equity (ROE)	-14.42%	-18.05%	-5.92%	-15.14%	-534.39%	-
Return on Assets (ROA)	-8.42%	-8.55%	-10.33%	-9.17%	-15.64%	-48.59%
Return on Capital Employed (ROCE)	-14.90%	-15.40%	-17.70%	-16.20%	-18.30%	-129.50%
Earnings Yield	-39.46%	-75.46%	-11.58%	-10.22%	-21.57%	-
FCF Yield	-38.96%	-55.85%	-39.35%	-10.47%	-4.56%	-
Buyback Yield / Dilution	0.28%	-0.29%	-0.64%	-64.78%	-129.57%	-7.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.